throbber
Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30334 Page 1 of
`25
`
`
`
`
`
`
`
`
`
`
`
`EXHIBIT 35
`
`TO DECLARATION OF CHRISTIANA GARRETT
`IN SUPPORT OF NUVASIVE, INC.’S
`REPLY IN SUPPORT OF
`MOTION FOR PARTIAL SUMMARY JUDGMENT
`AND MOTION TO EXCLUDE EXPERT OPINIONS
`(IMPLANT PATENTS)
`
`
`
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30335 Page 2 of
`25
`
`· · · · · · UNITED STATES DISTRICT COURT
`
`· · · · · ·SOUTHERN DISTRICT OF CALIFORNIA
`
`· · · · · · · · ·SAN DIEGO DIVISION
`
`NUVASIVE, INC., a Delaware
`corporation,
`
`· · · · · Plaintiff,
`
`· · · · · v.· · · · ·Case No. 3:18-CV-00347
`· · · · · · · · · · · · · · · -CAB-MDD
`ALPHATEC HOLDINGS, INC., a
`Delaware corporation and
`ALPHATEC SPINE, INC., a
`California corporation,
`
`· · · · · Defendants.
`
`_______________________________________________________
`
`· · ·HIGHLY CONFIDENTIAL - ATTORNEYS' EYES ONLY
`
`· · · · VIDEOTAPED DEPOSITION OF FRANK CHANG
`
`· ·ALPHATEC’S HOLDINGS, INC. RULE 30(b)(6) WITNESS
`
`· · · · · · · · SAN DIEGO, CALIFORNIA
`
`· · · · · · · · · JANUARY 15, 2020
`
`REPORTED BY:· PATRICIA Y. SCHULER, CSR No. 11949
`
`EXHIBIT 35
`Page 126
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30336 Page 3 of
`25
`
`·1· · · · · · · ·UNITED STATES DISTRICT COURT
`
`·2· · · · · · · SOUTHERN DISTRICT OF CALIFORNIA
`
`·3· · · · · · · · · · SAN DIEGO DIVISION
`
`·4
`
`·5· ·NUVASIVE, INC., a Delaware
`· · ·corporation,
`·6
`· · · · · · · ·Plaintiff,
`·7
`· · · · · · · ·v.· · · · · · ·Case No. 3:18-CV-00347
`·8· · · · · · · · · · · · · · · · · · ·-CAB-MDD
`· · ·ALPHATEC HOLDINGS, INC., a
`·9· ·Delaware corporation and
`· · ·ALPHATEC SPINE, INC., a
`10· ·California corporation,
`
`11· · · · · · ·Defendants.
`
`12· ·_______________________________________________________
`
`13· · · · Videotaped deposition of FRANK CHANG, taken on
`
`14· ·behalf of the Defendants at 12235 El Camino Real,
`
`15· ·Suite 100, San Diego, California, at 9:03 a.m. and
`
`16· ·ending at 6:17 p.m., on January 15, 2020, before
`
`17· ·PATRICIA Y. SCHULER, Certified Shorthand Reporter
`
`18· ·No. 11949.
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`EXHIBIT 35
`Page 127
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30337 Page 4 of
`25
`
`·1· ·APPEARANCES:
`
`·2· ·FOR PLAINTIFF:
`
`·3· · · · · · ·WILSON SONSINI GOODRICH & ROSATI, P.C.
`
`·4· · · · · · ·BY:· PAUL D. TRIPODI, II, ESQ.
`
`·5· · · · · · ·633 West Fifth Street
`
`·6· · · · · · ·Suite 1550
`
`·7· · · · · · ·Los Angeles, California· 90071
`
`·8· · · · · · ·Ptripodi@wsgr.com
`
`·9· · · · · · ·- and -
`
`10· · · · · · ·WILSON SONSINI GOODRICH & ROSATI, P.C.
`
`11· · · · · · ·BY:· CHRISTINA DASHE, ESQ.
`
`12· · · · · · ·12235 El Camino Real
`
`13· · · · · · ·Suite 200
`
`14· · · · · · ·San Diego, California· 92130
`
`15· · · · · · ·CDashe@wsgr.com
`
`16· ·FOR DEFENDANTS:
`
`17· · · · · · ·WINSTON STRAWN LLP
`
`18· · · · · · ·BY:· BRIAN J. NISBET, ESQ.
`
`19· · · · · · ·35 West Wacker Drive
`
`20· · · · · · ·Chicago, Illinois 60601-9703
`
`21· · · · · · ·bnisbet@winston.com
`
`22· ·VIDEOGRAPHER:· TY PAULSON
`
`23· ·ALSO PRESENT:· TYSON MARSHALL
`
`24· · · · · · · · · KATE CORLEW
`
`25
`
`EXHIBIT 35
`Page 128
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30338 Page 5 of
`25
`
`·1· · · · · · · · · · · · ·I-N-D-E-X
`
`·2· ·WITNESS:· · · · · · · · · · · · · · · · ·EXAMINATION
`
`·3· ·FRANK CHANG· · · · · · · · · · · · · · · · · · ·PAGE
`
`·4· ·MS. DASHE· · · · · · · · · · · · · · · · · · · · · 9
`
`·5
`
`·6· · · · · · · · · · · E-X-H-I-B-I-T-S
`
`·7· ·PLAINTIFF'S· · · · · · · · · · · · · · · · · · ·PAGE
`
`·8· ·Exhibit 1· · ·Document entitled "NuVasive· · · · ·13
`· · · · · · · · · ·Inc.'s Amended Second Notice of
`·9· · · · · · · · ·Deposition of Alphatec Holdings
`· · · · · · · · · ·Inc. and Alphatec Spine Inc.
`10· · · · · · · · ·pursuant to rule 30(b)6"
`
`11· ·Exhibit 2· · ·Document entitled "NuVasive· · · · ·14
`· · · · · · · · · ·Inc.'s Second Notice of
`12· · · · · · · · ·Deposition of Alphatec Holdings
`· · · · · · · · · ·Inc. and Alphatec Spine Inc.
`13· · · · · · · · ·pursuant to rule 30(b)6"
`
`14· ·Exhibit 3· · ·Document entitled "2016· · · · · · ·79
`· · · · · · · · · ·Performance Management Form"
`15
`· · ·Exhibit 4· · ·Document entitled "LLIF Retractor· ·90
`16· · · · · · · · ·Test Protocol" dated January 7,
`· · · · · · · · · ·2015
`17
`· · ·Exhibit 5· · ·Document Bates stamped· · · · · · · 92
`18· · · · · · · · ·ATEC_LLIF000151174
`
`19· ·Exhibit 6· · ·Document Bates stamped ATEC_LLIF· · 95
`· · · · · · · · · ·863096
`20
`· · ·Exhibit 7· · ·Document entitled "Battalion· · · ·148
`21· · · · · · · · ·Lateral Lumbar Spacer System,"
`· · · · · · · · · ·Bates stamped NUVA_ATEC00144447
`22· · · · · · · · ·through 14475
`
`23· ·Exhibit 8· · ·Document entitled "Case Notes,"· · 175
`· · · · · · · · · ·Bates stamped ATEC_LLIF000854960
`24· · · · · · · · ·through 963
`
`25
`
`EXHIBIT 35
`Page 129
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30339 Page 6 of
`25
`
`·1· · · · · · · · E-X-H-I-B-I-T-S (CONTINUED)
`
`·2· ·PLAINTIFF'S· · · · · · · · · · · · · · · · · · ·PAGE
`
`·3· ·Exhibit 9· · ·Document entitled "Case Notes,"· · 191
`· · · · · · · · · ·Bates stamped ATEC_LLIF000854978
`·4· · · · · · · · ·through 983
`
`·5· ·Exhibit 10· · Document entitled "Case Notes,"· · 207
`· · · · · · · · · ·Bates stamped ATEC_LLIF00854994
`·6· · · · · · · · ·through 999
`
`·7· ·Exhibit 11· · Document entitled "Case Notes,"· · 223
`· · · · · · · · · ·Bates stamped ATEC_LLIF000855000
`·8· · · · · · · · ·through 004
`
`·9· ·Exhibit 12· · Document entitled "Case Notes,"· · 234
`· · · · · · · · · ·Bates stamped ATEC_LLIF000855000
`10· · · · · · · · ·through 11
`
`11· ·Exhibit 13· · Document entitled "Case Notes,"· · 242
`· · · · · · · · · ·Bates stamped ATEC_LLIF000672779
`12· · · · · · · · ·through 782
`
`13· ·Exhibit 14· · Document entitled "Squadron with· ·254
`· · · · · · · · · ·Arsenal case review, Paul Sawin
`14· · · · · · · · ·M.D.," Bates stamped
`· · · · · · · · · ·ATEC_LLIF00618461 through 480
`15
`· · ·Exhibit 15· · Document entitled "Visiting· · · · 261
`16· · · · · · · · ·Surgeon Program," Bates stamped
`· · · · · · · · · ·ATEC_LLIF00004729
`17
`· · ·Exhibit 16· · Document entitled "R&D Meeting,· · 268
`18· · · · · · · · ·Bates stamped ATEC_LLIF000627235
`
`19· ·Exhibit 17· · Defendant's Second Amended· · · · ·276
`· · · · · · · · · ·Response to Plaintiff NuVasive,
`20· · · · · · · · ·Inc.'s First Set of
`· · · · · · · · · ·Interrogatories, No. 2"
`21
`· · ·Exhibit 18· · Verification· · · · · · · · · · · ·276
`22
`· · ·Exhibit 19· · Document entitled "Defendant's· · ·282
`23· · · · · · · · ·Responses to Plaintiff NuVasive,
`· · · · · · · · · ·Inc.'s Third Set of
`24· · · · · · · · ·Interrogatories, No. 17"
`
`25
`
`EXHIBIT 35
`Page 130
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30340 Page 7 of
`25
`
`·1· · · · · · · · E-X-H-I-B-I-T-S (CONTINUED)
`
`·2· ·PLAINTIFF'S· · · · · · · · · · · · · · · · · · ·PAGE
`
`·3· ·Exhibit 20· · Redacted and excerpted portion of· 296
`· · · · · · · · · ·the rebuttal expert report of
`·4· · · · · · · · ·Keith Ugone, Ph.D., dated
`· · · · · · · · · ·December 4, 2019
`·5
`· · ·Exhibit 21· · Emails Bates stamped· · · · · · · ·322
`·6· · · · · · · · ·ATEC_LLIF000856178 through 180
`
`·7· ·Exhibit 22· · Document entitled "Attachment 4,· ·330
`· · · · · · · · · ·surgeon survey," Bates stamped
`·8· · · · · · · · ·ATEC_LLIF 200864 through 889
`
`·9· ·Exhibit 23· · Document entitled "Lateral· · · · ·340
`· · · · · · · · · ·Training," Bates stamped
`10· · · · · · · · ·ATEC_LLIF000878140 through 171
`
`11· ·Exhibit 24· · Document entitled "Market Launch· ·344
`· · · · · · · · · ·Plan," Bates stamped
`12· · · · · · · · ·ATEC_LLIF000862396 through 403
`
`13· ·Exhibit 25· · Document Bates stamped· · · · · · ·345
`· · · · · · · · · ·ATEC_LLIF000924924
`14
`· · ·Exhibit 26· · Document entitled "A Powerful· · · 348
`15· · · · · · · · ·Value Creation Opportunity,"
`· · · · · · · · · ·Bates stamped ATEC_LLIF000942942
`16· · · · · · · · ·through 958
`
`17· ·Exhibit 27· · Document Bates stamped· · · · · · ·350
`· · · · · · · · · ·ATEC_LLIF000921912 through 943
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`EXHIBIT 35
`Page 131
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30341 Page 8 of
`25
`
`·1· ·SAN DIEGO, CALIFORNIA; WEDNESDAY, JANUARY 15, 2020
`
`·2· · · · · · · · · · · · ·9:03 a.m.
`
`·3· · · · · · ·THE VIDEOGRAPHER:· Good morning.· We are
`
`·4· ·on the record at 9:03 a.m., on January 15, 2020.
`
`·5· ·Audio and video recording will continue to take
`
`·6· ·place until all parties agree to go off the record.
`
`·7· ·Please note that the microphones are sensitive and
`
`·8· ·may pick up whispering and private conversations.
`
`·9· · · · · · ·This is a video-recorded deposition of
`
`10· ·Frank Chang, in the matter of NuVasive v. Alphatec
`
`11· ·Holdings, taken by counsel for the plaintiffs,
`
`12· ·filed in the United States District Court, Southern
`
`13· ·District of California, San Diego Division.
`
`14· · · · · · ·This deposition is taking place at
`
`15· ·Wilson, Sonsini, Goodrich & Rosati, located at
`
`16· ·12235 El Camino Real, in San Diego, California
`
`17· ·92130.
`
`18· · · · · · ·My name is Ty Paulson.· I am the
`
`19· ·videographer on behalf of U.S. Legal Support,
`
`20· ·located at 1230 Columbia Street, Suite 400, in
`
`21· ·San Diego, California 92101.
`
`22· · · · · · ·The court reporter is Patricia Schuler,
`
`23· ·on behalf of U.S. Legal Support.· I am not related
`
`24· ·to any party in this action, nor am I financially
`
`25· ·interested in the outcome.
`
`EXHIBIT 35
`Page 132
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30342 Page 9 of
`25
`
`·1· · · · · · ·Counsel will state their appearances for
`
`·2· ·the record, after which the court reporter will
`
`·3· ·swear in the witness.
`
`·4· · · · · · ·MS. DASHE:· Christina Dashe from Wilson
`
`·5· ·Sonsini Goodrich & Rosati, on behalf of plaintiff
`
`·6· ·NuVasive.· With me is my colleague Paul Tripodi,
`
`·7· ·also of Wilson Sonsini, as well as Kate Corlew of
`
`·8· ·NuVasive.
`
`·9· · · · · · ·MR. NISBET:· Brian Nisbet with Winston &
`
`10· ·Strawn, on behalf of the Alphatec entities and the
`
`11· ·witness.· With me is Tyson Marshall, counsel with
`
`12· ·Alphatec.
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`EXHIBIT 35
`Page 133
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30343 Page 10 of
`25
`
`·1· · · · · · · · · · · ·FRANK CHANG,
`
`·2· · called as a witness, having been duly sworn by the
`
`·3· · · court reporter, was examined and testified as
`
`·4· · · · · · · · · · · · ·follows:
`
`·5
`
`·6· · · · · · · · · · · · EXAMINATION
`
`·7· ·BY MS. DASHE:
`
`·8· · · · Q.· ·Good morning.
`
`·9· · · · A.· ·Hi.
`
`10· · · · Q.· ·Please state and spell your full name for
`
`11· ·the record.
`
`12· · · · A.· ·Frank Chang, F-R-A-N-K, C-H-A-N-G.
`
`13· · · · Q.· ·Where do you currently live?
`
`14· · · · A.· ·Carlsbad.
`
`15· · · · Q.· ·California?
`
`16· · · · A.· ·California.
`
`17· · · · Q.· ·Who is your current employer?
`
`18· · · · A.· ·Alphatec Spine.
`
`19· · · · Q.· ·How long have you been employed at
`
`20· ·Alphatec?
`
`21· · · · A.· ·A little over four years.
`
`22· · · · Q.· ·What is your current title?
`
`23· · · · A.· ·Senior design engineer.
`
`24· · · · Q.· ·Have you ever been deposed before?
`
`25· · · · A.· ·No.
`
`EXHIBIT 35
`Page 134
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30344 Page 11 of
`25
`
`·1· ·accused products?
`
`·2· · · · · · ·Do you see that?
`
`·3· · · · A.· ·Okay.· I do see that.
`
`·4· · · · Q.· ·Do you understand, then, that NuVasive
`
`·5· ·generally asked Alphatec to identify any
`
`·6· ·alternative designs or alternative methods that
`
`·7· ·Alphatec contends to be acceptable alternatives to
`
`·8· ·the Battalion lateral system?
`
`·9· · · · A.· ·Recently?
`
`10· · · · · · ·MR. NISBET:· Object to the form of the
`
`11· ·question.
`
`12· ·BY MS. DASHE:
`
`13· · · · Q.· ·It's a document dated October 2019.
`
`14· · · · A.· ·No.
`
`15· · · · Q.· ·What do you understand that sentence to
`
`16· ·be asking?
`
`17· · · · · · ·MR. NISBET:· Object to the form of the
`
`18· ·question.· It is outside the scope.· He doesn't
`
`19· ·have any personal knowledge of it, so I'm not sure
`
`20· ·what the point of that inquiry is.
`
`21· · · · · · ·But you can answer, to the extent you
`
`22· ·understand it.
`
`23· · · · · · ·THE WITNESS:· I'm not really sure. I
`
`24· ·guess whatever the accused product is.· You're
`
`25· ·asking if we have any prospective alternative
`
`EXHIBIT 35
`Page 135
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30345 Page 12 of
`25
`
`·1· ·design or alternative method that we contend to be
`
`·2· ·acceptable and noninfringing to that.
`
`·3· ·BY MS. DASHE:
`
`·4· · · · Q.· ·If you go to Page 5, the first bullet.
`
`·5· ·Do you see where it says "Medtronic retractor
`
`·6· ·systems and surgical techniques, including without
`
`·7· ·limitation Direct Lateral Interbody Fusion (DLIF)
`
`·8· ·and MAST QUADRANT"?
`
`·9· · · · A.· ·Okay.
`
`10· · · · Q.· ·Are you familiar with Medtronic's DLIF or
`
`11· ·MAST QUADRANT?
`
`12· · · · · · ·MR. NISBET:· Object to the form.
`
`13· · · · · · ·THE WITNESS:· I have heard of DLIF, but I
`
`14· ·don't know what it looks like.
`
`15· ·BY MS. DASHE:
`
`16· · · · Q.· ·What have you heard about DLIF?
`
`17· · · · A.· ·That it is direct lateral interbody
`
`18· ·fusion.
`
`19· · · · Q.· ·Is that a lateral access system?
`
`20· · · · A.· ·I have heard of DLIF.· That's about as
`
`21· ·much as I know.· I don't know what is included in
`
`22· ·DLIF.· I have never seen what the tools they
`
`23· ·provide are.
`
`24· · · · Q.· ·Have you ever seen a DLIF surgical guide?
`
`25· · · · A.· ·No.
`
`EXHIBIT 35
`Page 136
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30346 Page 13 of
`25
`
`·1· · · · Q.· ·Do you have any idea what the DLIF --
`
`·2· ·Medtronic DLIF system looks like at all?
`
`·3· · · · A.· ·No.
`
`·4· · · · Q.· ·Have you heard of an entity called
`
`·5· ·Warsaw?
`
`·6· · · · A.· ·Come again?
`
`·7· · · · Q.· ·Warsaw, W-a-r-s-a-w.
`
`·8· · · · A.· ·Like the place in Indiana?
`
`·9· · · · Q.· ·Yes.· Actually, yes.
`
`10· · · · A.· ·Like have I heard -- I have heard of
`
`11· ·Warsaw, Indiana.· I don't know if that is a company
`
`12· ·or an item.· Sorry.
`
`13· · · · Q.· ·You can set that aside.
`
`14· · · · · · ·If you go back to Exhibit 1, please.
`
`15· · · · · · ·MR. NISBET:· Can we take a quick break?
`
`16· · · · · · ·MS. DASHE:· Yeah.· Actually, I think I'm
`
`17· ·transitioning, so we'll take a break.
`
`18· · · · · · ·MR. NISBET:· Okay.
`
`19· · · · · · ·THE WITNESS:· Okay.
`
`20· · · · · · ·THE VIDEOGRAPHER:· We're off the record
`
`21· ·at 4:28 p.m.
`
`22· · · · · · ·(Recess taken.)
`
`23· · · · · · ·THE VIDEOGRAPHER:· We're back on the
`
`24· ·record at 4:39 p.m.
`
`25· ·///
`
`EXHIBIT 35
`Page 137
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30347 Page 14 of
`25
`
`·1· ·BY MS. DASHE:
`
`·2· · · · Q.· ·Welcome back, Mr. Chang.· Before we
`
`·3· ·broke, I had you pull out Exhibit 1.
`
`·4· · · · · · ·Do you have that in front of you?
`
`·5· · · · A.· ·I do.
`
`·6· · · · Q.· ·If you go to Page 10, again, please, and
`
`·7· ·go to Topic No. 6.· Let me know when you're there.
`
`·8· · · · A.· ·6?
`
`·9· · · · Q.· ·Yes.
`
`10· · · · A.· ·Yes.
`
`11· · · · Q.· ·Do you understand that you have been
`
`12· ·designated to provide testimony regarding
`
`13· ·Alphatec's corporate knowledge regarding Topic
`
`14· ·No. 6?
`
`15· · · · A.· ·Yes.
`
`16· · · · · · ·MR. NISBET:· And, again, subject to
`
`17· ·conversations and objections.
`
`18· ·BY MS. DASHE:
`
`19· · · · Q.· ·Do you see that Topic 6 is "Alphatec's
`
`20· ·ability to develop bring to market a two-bladed
`
`21· ·retractor according to the Warsaw patents -- and it
`
`22· ·lists three patents -- including Alphatec's
`
`23· ·development time and cost of developing and
`
`24· ·manufacturing a two-bladed retractor and market
`
`25· ·acceptance of a two-bladed retractor."
`
`EXHIBIT 35
`Page 138
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30348 Page 15 of
`25
`
`·1· · · · · · ·Do you see that?
`
`·2· · · · A.· ·I see that.
`
`·3· · · · Q.· ·Does the usage of the term "Warsaw
`
`·4· ·patent" in Topic 6 help refresh your recollection
`
`·5· ·as to who Warsaw may be?
`
`·6· · · · A.· ·No.
`
`·7· · · · Q.· ·Do you see the three patents listed under
`
`·8· ·Topic 6?
`
`·9· · · · A.· ·I do.
`
`10· · · · Q.· ·Did you look at those three patents in
`
`11· ·preparing for your deposition testimony today?
`
`12· · · · A.· ·I have not.
`
`13· · · · Q.· ·Do you have any patents?
`
`14· · · · A.· ·No.
`
`15· · · · Q.· ·What did you do to prepare to provide
`
`16· ·Alphatec's knowledge with respect to Topic 6?
`
`17· · · · A.· ·I spoke to our counsel and Scott.
`
`18· · · · Q.· ·What did you speak with Scott Robinson
`
`19· ·about?
`
`20· · · · A.· ·General information on what it takes.
`
`21· · · · Q.· ·What do you mean by "what it takes"?
`
`22· · · · A.· ·What resources are necessary.· Again, I'm
`
`23· ·a design engineer, not a budgeting expert or a --
`
`24· ·what do you want to call it?· Just an executive in
`
`25· ·R & D who has seen the entire process from above.
`
`EXHIBIT 35
`Page 139
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30349 Page 16 of
`25
`
`·1· · · · Q.· ·And what -- what are the -- strike that.
`
`·2· · · · · · ·What resources -- strike that.
`
`·3· · · · · · ·What is your understanding of the
`
`·4· ·two-bladed retractor referred to in Topic 6?
`
`·5· · · · · · ·MR. NISBET:· Objection to the form;
`
`·6· ·vague.
`
`·7· · · · · · ·THE WITNESS:· In Topic 6?
`
`·8· ·BY MS. DASHE:
`
`·9· · · · Q.· ·Yes.
`
`10· · · · A.· ·It would be a retractor with two blades.
`
`11· · · · Q.· ·What did Scott Robinson tell you about
`
`12· ·the resource required to develop a two-bladed
`
`13· ·retractor?
`
`14· · · · A.· ·In relation to what aspect?· Materials?
`
`15· · · · Q.· ·Generally, what did he tell you during
`
`16· ·your conversations in preparing for today's
`
`17· ·deposition?
`
`18· · · · A.· ·That we had the ability at that time to
`
`19· ·do so, or -- and still do.
`
`20· · · · Q.· ·Is this a two-bladed retractor for
`
`21· ·lateral surgery?
`
`22· · · · A.· ·Yes.
`
`23· · · · Q.· ·What else did Scott Robinson tell you in
`
`24· ·your conversations regarding this topic?
`
`25· · · · A.· ·To perform -- or to -- sorry.· To bring
`
`EXHIBIT 35
`Page 140
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30350 Page 17 of
`25
`
`·1· ·to market a two-bladed retractor, we would require,
`
`·2· ·obviously, certain resources.· Those being
`
`·3· ·engineering resources, possibly a surgeon team,
`
`·4· ·prototyping -- so machine, time, and materials.
`
`·5· · · · Q.· ·What is machine time and materials?
`
`·6· · · · A.· ·To get something like an access
`
`·7· ·instrument done, or really any instrument cut out
`
`·8· ·of metal -- all instruments are pretty much cut out
`
`·9· ·of metal unless they're PEK or plastic -- but even
`
`10· ·then, you need machine time.· You know, need to
`
`11· ·basically reserve time on a machine from a
`
`12· ·manufacturer, or within our own capacities within
`
`13· ·our company in the machine shop we call "tag."· So
`
`14· ·reserving time in tag to have prototypes made which
`
`15· ·speeds up the process mightily.
`
`16· · · · Q.· ·Aside from speaking with Scott Robinson
`
`17· ·and counsel, did you do anything else to prepare to
`
`18· ·provide Alphatec's knowledge with respect to Topic
`
`19· ·6?
`
`20· · · · A.· ·No.
`
`21· · · · Q.· ·Did you look at any documents?
`
`22· · · · A.· ·No.
`
`23· · · · Q.· ·Alphatec did not actually develop a
`
`24· ·two-bladed lateral retractor, did it?
`
`25· · · · A.· ·At that time?
`
`EXHIBIT 35
`Page 141
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30351 Page 18 of
`25
`
`·1· · · · Q.· ·At any time.
`
`·2· · · · A.· ·We have nothing on the market.
`
`·3· · · · Q.· ·You do not have a commercially available
`
`·4· ·two-bladed retractor for lateral fusion surgery; is
`
`·5· ·that correct?
`
`·6· · · · A.· ·That is correct.
`
`·7· · · · Q.· ·Have you ever had a two-bladed -- has
`
`·8· ·Alphatec ever had a two-bladed retractor for
`
`·9· ·lateral fusion spine surgery?
`
`10· · · · A.· ·How is that different from the last
`
`11· ·question?· No, we -- we do not have a commercially
`
`12· ·available retractor, and nor have we had one in the
`
`13· ·past.· Sorry.
`
`14· · · · Q.· ·So this two-bladed retractor that you
`
`15· ·spoke with Mr. Robinson about, that would be a
`
`16· ·hypothetical retractor; is that right?
`
`17· · · · A.· ·We are currently in development of one as
`
`18· ·well.
`
`19· · · · Q.· ·When you spoke with Mr. Robinson, did you
`
`20· ·rely on any of -- excuse me.
`
`21· · · · · · ·When you spoke with Mr. Robinson, did he
`
`22· ·rely on any of Alphatec's experiences with the
`
`23· ·current development of a two-bladed retractor?
`
`24· · · · A.· ·No.· We were talking -- we were talking
`
`25· ·hypotheticals on that time while we were developing
`
`EXHIBIT 35
`Page 142
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30352 Page 19 of
`25
`
`·1· ·the three, if we went to a two, was it possible,
`
`·2· ·and from what I understand, yes, it was possible.
`
`·3· · · · Q.· ·So in preparing for giving testimony on
`
`·4· ·behalf of Alphatec with respect to Topic 6, you
`
`·5· ·were discussing a hypothetical two-bladed
`
`·6· ·retractor; is that right?
`
`·7· · · · A.· ·Yes.
`
`·8· · · · Q.· ·You also said that you're currently in
`
`·9· ·development of a two-bladed retractor?
`
`10· · · · A.· ·That is part of our agenda in 2020.
`
`11· · · · Q.· ·That is --
`
`12· · · · A.· ·Well, 2019-2020.
`
`13· · · · Q.· ·When I say, "you," I mean Alphatec has it
`
`14· ·on its agenda --
`
`15· · · · A.· ·Yes.
`
`16· · · · Q.· ·-- to develop?
`
`17· · · · A.· ·Yes.
`
`18· · · · Q.· ·Is that a lateral retractor?
`
`19· · · · A.· ·I'm actually not privy to what it's
`
`20· ·actually going to be used for.· Potentially, but...
`
`21· · · · Q.· ·So you don't know if the two-bladed
`
`22· ·retractor for development on Alphatec's agenda will
`
`23· ·be used for lateral or something else; is that
`
`24· ·right?
`
`25· · · · A.· ·I think it might be.
`
`EXHIBIT 35
`Page 143
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30353 Page 20 of
`25
`
`·1· · · · Q.· ·Might be used for lateral?
`
`·2· · · · A.· ·It might be, yes.
`
`·3· · · · Q.· ·And how do you know that?
`
`·4· · · · A.· ·Just based on what Scott mentioned.
`
`·5· · · · Q.· ·What did Scott mention?
`
`·6· · · · A.· ·That it -- I think he might have said
`
`·7· ·that it would be used for lateral, but I'm not
`
`·8· ·sure.
`
`·9· · · · Q.· ·And that's Scott Robinson?
`
`10· · · · A.· ·That is Scott Robinson.
`
`11· · · · Q.· ·Is Scott Robinson involved in developing
`
`12· ·the two-bladed retractor that Alphatec has on its
`
`13· ·agenda for 2020?
`
`14· · · · A.· ·No.
`
`15· · · · Q.· ·Do you know who is?
`
`16· · · · A.· ·The access team.
`
`17· · · · Q.· ·What is the access team?
`
`18· · · · A.· ·It's a branch of our product development
`
`19· ·team.
`
`20· · · · Q.· ·Is the two-bladed retractor that Alphatec
`
`21· ·has on its agenda to development in 2020, is that
`
`22· ·meant to be used in conjunction with the Squadron
`
`23· ·retractor?
`
`24· · · · A.· ·No.
`
`25· · · · Q.· ·Is it intended to replace the Squadron
`
`EXHIBIT 35
`Page 144
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30354 Page 21 of
`25
`
`·1· ·retractor?
`
`·2· · · · A.· ·No.
`
`·3· · · · Q.· ·But it might be used for lateral; is that
`
`·4· ·correct?
`
`·5· · · · A.· ·I think so.
`
`·6· · · · Q.· ·And you're not part of the team
`
`·7· ·developing the two-bladed retractor, right?
`
`·8· · · · A.· ·No, I'm on interbody.
`
`·9· · · · Q.· ·If Alphatec had brought the hypothetical
`
`10· ·two-bladed retractor that you're discussing with
`
`11· ·respect to Topic 6, would Alphatec have had to get
`
`12· ·any sort of FDA clearance?
`
`13· · · · A.· ·No.
`
`14· · · · Q.· ·The actual two-bladed retractor that's
`
`15· ·being developed at Alphatec, similarly, that would
`
`16· ·not require any sort of FDA clearance, right?
`
`17· · · · A.· ·The current one?
`
`18· · · · Q.· ·Yes.
`
`19· · · · A.· ·Yes.
`
`20· · · · Q.· ·Do you know what the timeline is for
`
`21· ·developing the Alphatec two-bladed retractor?
`
`22· · · · · · ·MR. NISBET:· Are you talking about the --
`
`23· ·BY MS. DASHE:
`
`24· · · · Q.· ·The currently in development one?
`
`25· · · · A.· ·Oh, the timeline?
`
`EXHIBIT 35
`Page 145
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30355 Page 22 of
`25
`
`·1· · · · Q.· ·Um-hmm.
`
`·2· · · · A.· ·I think we started it in June of 2019,
`
`·3· ·and we're slated to finish within the year, if --
`
`·4· ·around that time.
`
`·5· · · · Q.· ·So that would be about a year and a half?
`
`·6· · · · A.· ·No, no, no.· Within a year.· So, yeah.
`
`·7· · · · Q.· ·Did Mr. Robinson -- strike that.
`
`·8· · · · · · ·So just to make sure that I'm clear, the
`
`·9· ·actual two-bladed retractor that's in development
`
`10· ·started in about June of 2019, and is currently
`
`11· ·slated to be completed on or around June of 2020;
`
`12· ·is that right?
`
`13· · · · A.· ·Yes.· Somewhere around there.
`
`14· · · · Q.· ·Do you know what the status is of the
`
`15· ·actual two-bladed retractor in development at
`
`16· ·Alphatec?
`
`17· · · · · · ·MR. NISBET:· Objection to form.
`
`18· · · · · · ·THE WITNESS:· The status of the current
`
`19· ·one?
`
`20· ·BY MS. DASHE:
`
`21· · · · Q.· ·Yes.
`
`22· · · · A.· ·In development.· I'm sorry, yeah, I'm not
`
`23· ·on the team.
`
`24· · · · Q.· ·Do you know if there's any prototypes?
`
`25· · · · A.· ·I can't speak to that.
`
`EXHIBIT 35
`Page 146
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30356 Page 23 of
`25
`
`·1· · · · · · ·I, PATRICIA Y. SCHULER, a Certified
`
`·2· ·Shorthand Reporter of the State of California, do
`
`·3· ·hereby certify:
`
`·4· · · · · · ·That the foregoing proceedings were taken
`
`·5· ·before me at the time and place herein set forth;
`
`·6· ·that any witnesses in the foregoing proceedings,
`
`·7· ·prior to testifying, were duly sworn; that a
`
`·8· ·verbatim record of the proceedings was made by me
`
`·9· ·using machine shorthand which was thereafter
`
`10· ·transcribed under my direction; that the foregoing
`
`11· ·transcript is a true record of the testimony given.
`
`12· · · · · · ·Further, that if the foregoing pertains
`
`13· ·to the original transcript of a deposition in a
`
`14· ·Federal Case, before completion of the proceedings,
`
`15· ·review of the transcript [X] was [ ] was not
`
`16· ·requested.
`
`17· · · · · · ·I further certify I am neither
`
`18· ·financially interested in the action nor a relative
`
`19· ·or employee of any attorney of party to this
`
`20· ·action.
`
`21· · · · · · ·IN WITNESS WHEREOF, I have this date
`
`22· ·subscribed my name.
`
`23· ·Dated:· January 16, 2020
`
`24· · · · · · · · · · · · · _________________________
`· · · · · · · · · · · · · · PATRICIA Y. SCHULER
`25· · · · · · · · · · · · · CSR NO. 11949
`
`EXHIBIT 35
`Page 147
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30357 Page 24 of
`25
`Deposition Errata Sheet
`Frank Chang
`Deposition Date: January 15,2020
`
`PAGE:LINE
`
`Original Testimony
`
`Corrected
`Testimony
`
`34:17
`
`40:3
`
`48:23
`
`79:17
`
`82:14
`
`83:14
`
`83:15
`
`99:10
`
`109:15
`
`120:20
`
`121:23
`
`136:12
`
`136:23
`
`142:7
`
`163:18
`
`182:6
`
`205:24
`
`206:9
`
`265:20
`
`272:4
`
`"technique"
`
`"discetomy"
`
`"A-C-F"
`
`"disrep"
`
`"pexalobe"
`
`"PEK"
`
`"PEK"
`
`"PEK"
`
`"system"
`
`"what"
`
`"SGG"
`
`"ACDF"
`
`"disc prep"
`
`"hexalobe"
`
`"PEEK"
`
`"PEEK"
`
`"PEEK"
`
`"assessment"
`
`"that"
`
`"STG"
`
`"primary K-wire"
`
`"primary, K-wire"
`
`"pull"
`
`"pull"
`
`"acuate"
`
`"I will be"
`
`"cattawa"
`
`"PEK"
`
`"PEK"
`
`"pawl"
`
`"pawl"
`
`"actuate"
`
`"we are very"
`
`"Cadwell"
`
`"PEEK"
`
`"PEEK"
`
`"Alicia Ruby"
`
`"Ali Shorooghi"
`
`"end"
`
`"AMP"
`
`REASON
`
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`
`EXHIBIT 35
`Page 148
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-11 Filed 02/26/21 PageID.30358 Page 25 of
`25
`Deposition Errata Sheet
`Frank Chang
`Deposition Date: January 15, 2020
`
`PAGE:LINE
`
`Original Testimony
`
`Corrected
`Testimony
`
`"TLIF"
`
`'TLIF"
`
`"PEEK"
`
`"PEEK"
`
`"QLIF"
`
`"PLIF"
`
`"PEK"
`
`"PEK"
`
`£>
`
`t&l o
`
`279:13
`
`279:14
`
`290:9
`
`324:10
`
`Date:
`
`Signature:
`
`Frank Chi
`
`REASON
`
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`To correct
`transcription errors
`
`AmericasActive: 14394708.1
`
`EXHIBIT 35
`Page 149
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket